Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 3/20 | 0.59 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8438979 | 0.91 | TAAR1 (0.58) | TBXA2RTBXAS1MEN1KMT2A | |
| SCHEMBL8442601 | 0.89 | TAAR1 (0.52) | TBXA2RTBXAS1MEN1KMT2APRMT1 | |
| SCHEMBL8438739 | 0.88 | ALDH1A1 (0.56) | TBXAS1MEN1KMT2AAKR1C3 | |
| SCHEMBL8437940 | 0.88 | TBXAS1 (0.50) | TBXA2RTBXAS1MEN1KMT2A | |
| SCHEMBL8438622 | 0.88 | TBXA2R (0.59) | TBXA2RTBXAS1MEN1KMT2APRMT1 | |
| SCHEMBL8441016 | 0.85 | ALDH1A1 (0.59) | MEN1KMT2AAKR1C3 | |
| SCHEMBL8441089 | 0.85 | CA1 (0.53) | TBXA2RTBXAS1MEN1KMT2A | |
| SCHEMBL9510805 | 0.81 | TBXA2R (0.60) | TBXA2RTBXAS1 | |
| SCHEMBL9754213 | 0.81 | TBXA2R (0.69) | TBXA2RTBXAS1PRMT1AKR1C3 | |
| SCHEMBL8441823 | 0.79 | MCL1 (0.39) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5955505-A | TREATING NERVE DEGENERATIVE DISORDERS | NIPPON SUISAN KAISHA, LTD. (JP) | 1999-09-21 | — | — | US | disclosed |